SIGN UP
LOG IN
M
MIST
Milestone Pharmaceuticals
1.43
-0.02-1.38%After Hours: 1.489 +0.059 +4.11%19:20 08/01 EDT
OPEN/PREV CLOSE1.410/1.450
TODAY RANGE1.400-1.480
VOL673.51K
MARKET CAP121.50M
52 WEEK RANGE0.6254-2.750
AVG VOL (3M)1.43M
% TURNOVER0.79%
TURNOVER--
P/E (TTM)-1.6649
% RANGE5.48%
EPS(TTM)-0.8589
P/E(FORWARD)-1.7229
P/B-12.4891
BVPS-0.1145
DIVIDEND--
P/S47.83
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP117.12M
SHARES OUTSTANDING84.96M
NEXT EARNINGS08/06-08/11
FREE FLOAT81.90M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·07/18 18:16
Milestone Pharmaceuticals Remains A Buying Opportunity Despite Recent Dilution
Simply Wall St·07/15 10:59
Retail investors who have a significant stake must be disappointed along with institutions after Milestone Pharmaceuticals Inc.'s (NASDAQ:MIST) market cap dropped by US$9.0m
TipRanks·07/14 13:07
TD Cowen Sticks to Its Hold Rating for Milestone Pharmaceuticals (MIST)
TipRanks·07/14 11:59
Milestone Pharmaceuticals Announces Public Offering for $48.7M
TipRanks·07/11 19:05
Milestone prices $52.5M common shares offering at $1.50 per share
Benzinga·07/11 18:37
Crude Oil Rises Sharply; Milestone Pharmaceuticals Shares Plunge
Benzinga·07/11 17:06
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·07/11 16:22
Why Is Milestone Pharmaceuticals Stock Plunging On Friday?
TipRanks·07/11 15:52
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
Dow Jones·07/11 14:55
Repeat & Correct: Milestone Pharmaceuticals Shares Decline on Public Offering
Benzinga·07/11 14:41
Dow Dips Over 200 Points; Levi Strauss Posts Upbeat Earnings
Seeking Alpha·07/11 14:41
Milestone Pharmaceuticals plunges after pricing $52.5M offering
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.